Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 302

1.

A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan.

Owada Y, Oshiro Y, Inagaki Y, Harada H, Fujiyama N, Kawagishi N, Yagisawa T, Usui J, Akutsu N, Itabashi Y, Saito K, Watarai Y, Ichimaru N, Imamura R, Kyakuno M, Ide K, Shibuya Y, Okabe Y, Ono M, Sasaki K, Shiose A, Yamagishi K, Ohnishi H, Nagashima S, Takahashi M, Yuzawa K, Okamoto H, Ohkohchi N.

Transplantation. 2019 May 20. doi: 10.1097/TP.0000000000002801. [Epub ahead of print]

PMID:
31205267
2.

Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature.

Sato K, Yamazaki Y, Kobayashi T, Takakusagi S, Horiguchi N, Kakizaki S, Andou M, Matsuda Y, Uraoka T, Ohnishi H, Okamoto H.

World J Clin Cases. 2019 May 6;7(9):1043-1052. doi: 10.12998/wjcc.v7.i9.1043.

3.

Genetic Variability and Evolution of Hepatitis E Virus.

Primadharsini PP, Nagashima S, Okamoto H.

Viruses. 2019 May 18;11(5). pii: E456. doi: 10.3390/v11050456. Review.

4.

Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).

Miyanaga A, Kubota K, Hosomi Y, Okuma Y, Minato K, Fujimoto S, Okamoto H, Satouchi M, Isobe H, Aono H, Takiguchi Y, Gemma A; Tokyo Cooperative Oncology Group.

Jpn J Clin Oncol. 2019 May 9. pii: hyz064. doi: 10.1093/jjco/hyz064. [Epub ahead of print]

PMID:
31070750
5.

Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains.

Nakano T, Okano H, Takahashi M, Nagashima S, Shiraki K, Oya Y, Inoue H, Ohmori S, Tsukimoto M, Ishida S, Fujimoto S, Kobayashi M, Yamawaki M, Kumagai M, Ninomiya J, Maegawa T, Kojima Y, Araki J, Hamaoka S, Horiike S, Yoshimura H, Takeuchi K, Itoh K, Akachi S, Uraki S, Yamamoto N, Ogura S, Sugimoto K, Yoshikawa K, Hasegawa H, Iwasa M, Takei Y, Okamoto H.

Hepatol Res. 2019 Apr 26. doi: 10.1111/hepr.13357. [Epub ahead of print]

PMID:
31026368
6.

Screening of novel drugs for inhibiting hepatitis E virus replication.

Nishiyama T, Kobayashi T, Jirintai S, Kii I, Nagashima S, Prathiwi Primadharsini P, Nishizawa T, Okamoto H.

J Virol Methods. 2019 Aug;270:1-11. doi: 10.1016/j.jviromet.2019.04.017. Epub 2019 Apr 17.

PMID:
31004661
7.

Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study.

Niho S, Hosomi Y, Okamoto H, Nihei K, Tanaka H, Hida T, Umemura S, Goto K, Akimoto T, Ohe Y.

Jpn J Clin Oncol. 2019 Mar 27. pii: hyz039. doi: 10.1093/jjco/hyz039. [Epub ahead of print]

PMID:
30916304
8.

Very low prevalence of anti-HAV in Japan: high potential for future outbreak.

Yamamoto C, Ko K, Nagashima S, Harakawa T, Fujii T, Ohisa M, Katayama K, Takahashi K, Okamoto H, Tanaka J.

Sci Rep. 2019 Feb 6;9(1):1493. doi: 10.1038/s41598-018-37349-1.

9.

Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.

Agemi Y, Shimokawa T, Sasaki J, Miyazaki K, Misumi Y, Sato A, Aida S, Ishii M, Nakamura Y, Naoki K, Okamoto H.

PLoS One. 2019 Jan 17;14(1):e0210499. doi: 10.1371/journal.pone.0210499. eCollection 2019.

10.

Full-genome characterization of the RIVM-HAV16-090-like hepatitis A virus strains recovered from Japanese men who have sex with men, with sporadic acute hepatitis A.

Watanabe S, Morimoto N, Miura K, Takaoka Y, Nomoto H, Tsukui M, Isoda N, Ohnishi H, Nagashima S, Takahashi M, Okamoto H, Yamamoto H.

Hepatol Res. 2019 May;49(5):521-530. doi: 10.1111/hepr.13313. Epub 2019 Feb 20.

PMID:
30645783
11.

Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.

Nanmoku K, Owada Y, Oshiro Y, Kurosawa A, Kubo T, Shinzato T, Shimizu T, Kimura T, Sakuma Y, Ishikawa N, Ohkohchi N, Okamoto H, Yagisawa T.

Transpl Infect Dis. 2019 Apr;21(2):e13033. doi: 10.1111/tid.13033. Epub 2018 Dec 14.

PMID:
30481402
12.

Dynamics of hepatitis B virus serum markers in an acute hepatitis B patient in the incubation phase.

Okamoto S, Yamasaki K, Komori A, Abiru S, Nagaoka S, Saeki A, Hashimoto S, Bekki S, Okamoto H, Yatsuhashi H.

Clin J Gastroenterol. 2019 Jun;12(3):218-222. doi: 10.1007/s12328-018-0925-6. Epub 2018 Nov 21.

PMID:
30465320
13.

Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.

Aiko N, Shimokawa T, Miyazaki K, Misumi Y, Agemi Y, Ishii M, Nakamura Y, Yamanaka T, Okamoto H.

BMC Cancer. 2018 Oct 22;18(1):1012. doi: 10.1186/s12885-018-4911-7.

14.

[Hepatitis E in patients with hematological disorders].

Okamoto H.

Rinsho Ketsueki. 2018;59(10):1914-1923. doi: 10.11406/rinketsu.59.1914. Japanese.

PMID:
30305492
15.

Identification and full-genome characterization of novel circoviruses in masked palm civets (Paguma larvata).

Nishizawa T, Sugimoto Y, Takeda T, Kodera Y, Hatano Y, Takahashi M, Okamoto H.

Virus Res. 2018 Oct 15;258:50-54. doi: 10.1016/j.virusres.2018.10.004. Epub 2018 Oct 5.

PMID:
30296458
16.

[Guillain-Barré syndrome associated with acute hepatitis A-A case report and literature review].

Saito A, Saito M, Shimoe Y, Yoshimoto T, Kawakami M, Okamoto H, Yoshikawa K, Kusunoki S, Kuriyama M.

Rinsho Shinkeigaku. 2018 Sep 28;58(9):574-577. doi: 10.5692/clinicalneurol.cn-001165. Epub 2018 Aug 31. Review. Japanese.

PMID:
30175808
17.

Identification and whole genome characterization of novel anelloviruses in masked palm civets (Paguma larvata): Segregation into four distinct clades.

Nishizawa T, Sugimoto Y, Takeda T, Kodera Y, Hatano Y, Takahashi M, Okamoto H.

Virus Res. 2018 Sep 2;256:183-191. doi: 10.1016/j.virusres.2018.08.015. Epub 2018 Aug 24.

PMID:
30149046
18.

Hepatitis E during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.

Ikeuchi H, Koinuma K, Nakasatomi M, Sakairi T, Kaneko Y, Maeshima A, Yamazaki Y, Okamoto H, Mimura T, Mochida S, Nojima Y, Hiromura K.

Case Rep Rheumatol. 2018 Jul 26;2018:6873276. doi: 10.1155/2018/6873276. eCollection 2018.

19.

Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression.

Win NN, Kanda T, Nakamoto S, Moriyama M, Jiang X, Suganami A, Tamura Y, Okamoto H, Shirasawa H.

Int J Med Sci. 2018 Jul 30;15(11):1153-1159. doi: 10.7150/ijms.27489. eCollection 2018.

20.

Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).

Atagi S, Mizusawa J, Ishikura S, Takahashi T, Okamoto H, Tanaka H, Goto K, Nakagawa K, Harada M, Takeda Y, Nogami N, Fujita Y, Kasai T, Kishi K, Sawa T, Takeda K, Tomii K, Satouchi M, Seto T, Ohe Y.

Clin Lung Cancer. 2018 Sep;19(5):e619-e627. doi: 10.1016/j.cllc.2018.04.018. Epub 2018 May 5.

PMID:
29887243

Supplemental Content

Loading ...
Support Center